Palvella Therapeutics (PVLA) Q4 2024 Earnings

13NovConfirmed
Q4 2024
-4
-3.06
-2.12
-1.18

Details

Expected EPS
-4
Actual EPS
-1.18
Surprise EPS
2.82
Surprise Percent
+70.5%

Description

Palvella Therapeutics (PVLA) has reported earnings of -1.18 per share for Q4 2024.

0 Comments

Share your thoughts